MME and Hypokalemia: Conversely, in cases of mild hypokalaemia in patients with HF, it is recommended to increase the dosage of ACEIs/ARBs/angiotensin receptor–neprilysin inhibitors (ARNIs) to meet guideline-recommended targets.